Activity record

PGDB_A081674

Assay: biochemicalTarget: CRBNQC: standardized
Activity overview

inhibition = 30-40 %

TargetCRBN
E3 ligaseCRBN
Concentration0.5 uM
Assay / ReadoutHTRF / % Inhibition
Assay IDPGDB_AS000662
PatentWO2026061475A1
QC statusstandardized
Evidence details

Compound, assay context, and source

Compound

2D structure for PGDB_C030398
Compound IDPGDB_C030398
CompoundGT-10661
Source record IDPGDB_C030398
InChIKeySDRDVIPDVVEFIA-UHFFFAOYSA-N

Assay context

Assay IDPGDB_AS000662
Assay familybiochemical
Assay systemcell_based
Readout% Inhibition
TechnologyHTRF
Concentration0.5 uM
Detection targetcell_inhibition
TargetCRBN
E3CRBN
OrganismHomo sapiens

Source evidence

Patent IDWO2026061475A1
Compound location

GT-10661

GT-10661 enlarged structureGT-10661 location on patent page 78
Activity table
Page 215 · table start
Page 216 · table end